医学
传统医学
药用植物
丹参
当归
黄芪
牛蒡
草药
肾小球肾炎
雷公藤甲素
中医药
肾
内科学
替代医学
生物
病理
细胞凋亡
生物化学
作者
Rainer Nowack,Felipe Flores-Suarez,Rainer Birck,Wilhelm H. Schmitt,Urs Benck
出处
期刊:Journal of Pharmacognosy and Phytotherapy
[Academic Journals]
日期:2011-10-31
卷期号:3 (9): 124-136
被引量:7
摘要
Remissions of nephrotic syndrome due to membranous nephropathy (MN) induced byAstragalus membranaceus have drawn nephrologists attention to medicinal herbs as alternative treatments of glomerulonephritis. MN stands for a group of chronic glomerulonephritides that are routinely treated with corticosteroids and cytotoxic drugs, although treatment responses are unsatisfactory and the toxic burden significant. The investigational status of Astragalus and other medicinal herbs like Angelica sinensis, Tripterygium wilfordii, Rheum palmatum, Ligusticum wallichii, Perilla frutescens, Salvia miltiorrhiza, Arctium lappa with respect to their use as treatments of chronic renal disease and specifically of glomerulonephritis is reviewed. Most of these herbs are in current clinical use in China and appear to have promising constituents capable of modifying immune processes in glomerulonephritis. Nevertheless, their application in patients can still not be advocated as clinical studies meeting international quality standards have not been performed and toxic risks had not been excluded with adequate scrutiny.
Key words: Glomerulonephritis, medicinal herbs, triptolide, astragalus, perilla, rhubarb.
科研通智能强力驱动
Strongly Powered by AbleSci AI